Clinical Trial Update: Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated With Elevated Serum Homocysteine in Hemodialysis Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether L-methylfolate and methylcobalamin reduce resistant hypertension associated with elevated homocysteine in hemodialysis patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Drugs mentioned

• L-methylfolate (L-methylfolate)
• Methylcobalamin (methylcobalamin)

Snippet

Sponsor: Alexandria University | Conditions: End Stage Renal Disease, Hypertension, Renal | Phase 4 | Status: COMPLETED